8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute with stronger metabolic modulator activity by Carrageta, David F et al.
Contents lists available at ScienceDirect
Toxicology in Vitro
journal homepage: www.elsevier.com/locate/toxinvit
8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute
with stronger metabolic modulator activity
David F. Carragetaa,b, Tânia R. Diasa,b, Ivana Jaraka,b,c, Marco G. Alvesb, Pedro F. Oliveirab,d,
Mietha M. Van der Walte,f, Gisella Terre'Blanchee, Mariana P. Monteirog, Branca M. Silvaa,⁎
aUniversity of Beira Interior, Rua Marquês d'Ávila e Bolama, 6201-001 Covilhã, Portugal
bDepartment of Microscopy, Laboratory of Cell Biology, Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar
(ICBAS), University of Porto, Rua Jorge Viterbo Ferreira, 4050-313 Porto, Portugal
c Department of Life Sciences, Faculty of Sciences and Technology and Centre for Functional Ecology (CFE), University of Coimbra, Coimbra, Portugal
d i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 4200-135 Porto, Portugal
e Centre of Excellence for Pharmaceutical Sciences, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa
fHuman Metabolomics, North-West University, Private Bag X6001, Box 269, Potchefstroom 2520, South Africa
g Department of Anatomy, Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua
Jorge Viterbo Ferreira, 4050-313 Porto, Portugal








A B S T R A C T
Caffeine is one of the most worldwide consumed methylxanthines. It is well-known for its thermogenic and cell
metabolism modulating effects. Based on methylxanthines' chemical structure, 8-(3-phenylpropyl)-1,3,7-trie-
thylxanthine (PTX) is a novel adenosine antagonist with higher receptor affinity than caffeine. Therefore, we
hypothesized that PTX metabolic effects could be stronger than those of caffeine. For that purpose, murine 3T3-
L1 cells were cultured in the presence of increasing doses of PTX or caffeine (0.1, 1, 10 and 100 μM) for 24 h.
Cytotoxicity was evaluated by reduction of tetrazolium salt (MTT) and lactate dehydrogenase (LDH) release. Cell
metabolites released to the culture medium were identified and quantified by proton nuclear magnetic resonance
(1H NMR). Cellular oxidative profile was also evaluated. Our results showed that PTX displayed no signs of
cytotoxicity at all studied concentrations. When compared with caffeine, PTX increased glucose, pyruvate, and
glutamine consumption, as well as lactate, alanine, and acetate production. Additionally, PTX decreased protein
oxidation, thus protecting against oxidative stress-induced damage. These results illustrate that PTX is a stronger
and less cytotoxic caffeine substitute with potential applications as metabolic modulator and a good candidate
for novel drug design.
1. Introduction
Caffeine (1,3,7-trimethylxanthine) (Fig. 1) is naturally present in
common food products, globally consumed on a daily basis and the
most well-characterized methylxanthine. The major sources of dietary
caffeine intake are coffee (Coffea sp.) and tea (Camelia sinensis) (Frary
et al. 2005). Caffeine exerts multiple physiological effects in the human
body, including stimulation of the sympathetic nervous system with
release of catecholamines (Acheson et al. 2004; Monteiro et al. 2018),
and modulation of glucose and fatty acids metabolism (Dulloo 2011;
Johansson et al. 2007), associated with increased mitochondrial ac-
tivity and biogenesis (Vaughan et al. 2012). Caffeine is also known to
boost physical exercise performance and endurance, being its use
common among athletes (Burke 2008). Caffeine principal mechanism of
action consists in the non-specific antagonism of adenosine receptors
(Carrageta et al. 2018; Monteiro et al. 2016). Caffeine and adenosine
have similar chemical structures, thus caffeine is able to block and in-
hibit the role of adenosine in cells in a competitive manner (Chen and
Chern 2011; Monteiro et al. 2018), such as in the human white adipose
tissue that highly expresses adenosine receptors (Vassaux et al. 1993).
Caffeine is known for its thermogenic and lipolytic effects, leading to fat
oxidation in adipocytes and release of fatty acids and glycerol to the
bloodstream (Carrageta et al. 2018; Dulloo 2011). Moreover, caffeine
consumption was reported to increase energy expenditure and promote
weight loss when associated with physical exercise and calorie re-
striction diets (Davoodi et al. 2014; Schubert et al. 2014). Furthermore,
several studies also demonstrated that caffeine in single or combined
use with other drugs, such as ephedrine or albuterol, enhanced the
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metabolic rate which led to weight loss (Dulloo and Miller 1986;
Greenway et al. 2004; Liu et al. 2015; Liu et al. 2013). Hence, caffeine
has been proposed as an adjuvant agent in obesity treatment.
Synthetic analogues of natural methylxanthines have been designed
for potential pharmaceutical application as anti-obesity agents (Moro
et al. 2006; Szkudelski et al. 2009). More recently, it was found that
ethyl substitutions at the positions 1, 3 and 7 of the caffeine structure
enhance the affinity for adenosine receptors (Van der Walt and
Terre'Blanche 2015). Moreover, substitutions at position 8 with aryl or
cycloalkyl groups were already reported as promising for the design of
novel adenosine receptor antagonists (Baraldi et al. 2007). As a result,
8-(3-phenylpropyl)-1,3,7-triethylxanthine (PTX) (Fig. 1) was described
as a novel, very potent adenosine A1 receptor antagonist obtained via
structural modifications of methylxanthines structure (Van der Walt
and Terre'Blanche 2015). In fact, PTX was reported to have Ki of
0.164 μM, while caffeine Ki for A1R is about 40–50 μM (Magkos and
Kavouras 2005). Herein, we hypothesize that this new analogue could
have stronger effects in the metabolic modulation than caffeine. Thus,
the aim of this study was to evaluate if PTX presents cytotoxic effects to
3T3-L1 cells and the potential of PTX in the modulation of cellular
metabolism. Since increased metabolic activity can lead to increased
oxidative stress levels (Dias et al. 2017) and this type of damage also
plays an important role in pathophysiology of obesity (Marseglia et al.
2014), the effects of caffeine and PTX exposure on oxidative stress was
also evaluated.
2. Materials and methods
2.1. Synthesis of 8-(3-phenylpropyl)-1,3,7-triethylxanthine (PTX)
PTX was synthesized and purified by HPLC (purity 87%) at the
School of Pharmacy, North-West University, Potchefstroom, South
Africa as previously described (Van der Walt and Terre'Blanche 2015;
Van der Walt et al. 2013).
2.2. Culture of mouse preadipocyte cell line 3T3-L1
Mouse preadipocyte cell line 3T3-L1 was purchased from a com-
mercial supplier (Zen-Bio, Durham, NC, USA) and cultured as pre-
viously described (Moreira et al. 2015). Cells were maintained in an
incubator at 37 °C with a 5% CO2 humidified atmosphere (Heracell
150i, Thermo Scientific, Waltham, MA, USA).
2.3. Experimental design
To evaluate the effects of caffeine and PTX on 3T3-L1 cells, nine
experimental groups were defined: a control group without caffeine
(powder, purity 99%, C53, Sigma-Aldrich, USA) nor PTX and eight
other groups with increasing doses of caffeine or PTX (0.1, 1, 10 and
100 μM). The stock solution of PTX was prepared in dimethyl sulfoxide
(DMSO) (Labkem, Ireland) and further diluted in culture medium to
obtain the intended concentrations. DMSO concentration in culture
media was normalized to 0.01% (v/v). After 24 h treatment (n=6 for
each condition), culture medium was collected and stored at−80 °C for
1H NMR analysis. Cells were then detached from the culture flask using
a trypsin-EDTA solution and collected for protein extraction. Total
number of cells and percentage of viability was assessed by LUNA™
Automated Cell Counter (Logos Biosystems, South Korea).
2.4. MTT viability assay
3T3-L1 cells were seeded in 96-wells plates and cultured as de-
scribed above (n=5 for each condition). After 24 h treatment, the
medium was removed and replaced with 150 μL of fresh culture
medium and 15 μL of MTT solution (5mg/mL in PBS) (Amresco, USA).
Plates were then incubated in a dark environment for 3.5 h at 37 °C.
After incubation, the culture medium was removed and 100 μL DMSO
were added, followed by agitation to solubilize the formazan crystals.
The absorbance was measured at 570 nm through an Anthos 2010 mi-
croplate reader (Biochrom, Berlin, Germany). Resulting values were
divided by the mean of the control group and expressed in fold varia-
tion to control group.
2.5. Lactate dehydrogenase (LDH) release assay
3T3-L1 cells were seeded in 96-wells plates and cultured as de-
scribed above (n= 5 for each condition). After 24 h treatment, 50 μL of
the culture medium was collected and transferred to a new 96-well
plate. LDH released to the extracellular medium was quantified by the
LDH Cytotoxicity Assay Kit (Thermo Scientific, Waltham, MA, USA)
according to the manufacturer's instructions. Fresh culture medium was
used as blank. Resulting values were divided by the mean of the control
group and expressed in fold variation to control group.
2.6. Proton nuclear magnetic resonance (1H NMR)
1H NMR spectra were acquired using previously described methods
(Alves et al. 2013). Cells were treated for 24 h, as described above
(n=6 for each condition). A total of 180 μL of culture medium of each
condition was analyzed. Samples were diluted with a sodium fumarate
(final concentration of 2mM) and deuterated water solution (final vo-
lume of 225 μL), which was used as internal reference (6.50 ppm) to
Fig. 1. – Chemical structures of caffeine and 8-(3-phenylpropyl)-1,3,7-trie-
thylxanthine (PTX).
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quantify the following metabolites present in cells culture medium
(multiplet, ppm): lactate (doublet, 1.33), alanine (doublet, 1.45),
acetate (singlet, 1.90), pyruvate (singlet, 2.34), H1-α-glucose (doublet,
5.22) and glutamine (multiplet, 2.45). Spectra were manually phased
and baseline corrected. Chosen metabolite peaks were integrated using
Amix-viewer (version 3.9.14, BrukerBiospin, Rheinstetten). Results are
expressed as μmol production or consumption per 106 cells.
2.7. Analysis of protein oxidation, protein nitration and lipid peroxidation
Total protein was extracted using M-PER (Thermo Scientific,
Waltham, MA, USA) according to the manufacturer's instructions.
Protein samples were then quantified using a BCA Protein Assay Kit
(Thermo Scientific, Waltham, MA, USA), according to the manufac-
turer's instructions. Protein oxidation, protein nitration and lipid per-
oxidation were analyzed by slot blot technique and specific antibodies,
according to methods previously described (Dias et al. 2015). Briefly,
for the analysis of protein oxidation the content of carbonyl groups was
evaluated by derivatization of 5 μg protein samples using 2,4-dini-
trophenylhydrazine (DNPH) to obtain 2,4-dinitrophenyl (DNP) and
followed by quantification. The slot-blot technique was performed
using a Hybri-slot manifold system (Biometra, Göttingen, Germany)
and the resulting PVDF membranes were incubated overnight at 4 °C
with a rabbit anti-DNP (1:5000, D9656, Sigma-Aldrich, St. Louis, MO,
USA). For evaluation of tyrosine residues nitration and lipid peroxida-
tion, protein samples were diluted to a concentration of 1 ng/μL using
PBS 1×. Then, two specific antibodies, rabbit anti-nitro-tyrosine
(1:5000, 9691S, Cell Signaling Technology, Netherlands) and goat anti-
4-hydroxynonenal (1:5000, AB5605, Merck Millipore, Temecula, USA)
respectively, were used. Samples were visualized using goat anti-rabbit
IgG-AP (1:5000, sc-2007, Santa Cruz Biotechnology, Heidelberg, Ger-
many) or rabbit anti-goat IgG-AP (1:5000, A4187, Sigma-Aldrich, St.
Louis, MO, USA). Membranes were then reacted with ECF™ substrate
(GE Healthcare, Buckinghamshire, UK) and read using a BioRad FX-Pro-
plus (Bio-Rad Hemel Hempstead, UK). Densities from each band were
quantified using the BIO-PROFIL Bio-1D Software from Quantity One
(VilberLourmat, Marne-la-Vallée, France). The density of each band
was divided by the mean density of the control group and expressed in
fold variation to the control group.
2.8. Statistical analysis
Statistical analysis was performed using the software GraphPad
Prism 6 (GraphPad software, USA). The statistical significance of the
groups was assessed by the student's t-test or by a one-way ANOVA,
followed by multiple comparisons through Fisher Least Significant
Difference (LSD) method. All experimental data are presented as
mean ± SEM and differences with p < .05 were considered sig-
nificant.
3. Results
3.1. PTX and caffeine cytotoxic effects in 3T3-L1 cells
The cytotoxic profiles of PTX and caffeine to 3T3-L1 cells were as-
sessed through two distinct in vitro assays. The MTT assay was per-
formed to evaluate the impact of the compounds on cells' metabolic
activity (Fig. 2A). Our results showed a reduction in the metabolic ac-
tivity (0.74 ± 0.06-fold variation to control) by caffeine at the highest
concentration (100 μM), while no alterations were induced by PTX at
any tested concentration.
To evaluate if the selected concentrations of caffeine or PTX could
cause cellular damage and cytolysis, the LDH released to the extra-
cellular medium was spectrophotometrically quantified (Fig. 2B). It was
observed that caffeine 100 μM induced a significant LDH release
(2.05 ± 0.10-fold variation to control), while PTX did not alter LDH
release relatively to the control group. Due to cellular toxicity induced
by the highest dose of caffeine (100 μM), this concentration was not
considered for the subsequent assays.
3.2. PTX increases 3T3-L1 cells glycolytic activity as compared with
caffeine
Caffeine is known to modulate cellular glucose metabolism (Lopes-
Silva et al. 2015). Hence, we evaluated the impact of the non-cytotoxic
doses (up to 10 μM) of PTX and caffeine on glucose metabolism of 3T3-
L1 cells. Under our experimental conditions we observed that caffeine,
at all the studied concentrations, did not increased glucose consump-
tion in 3T3-L1 cells as compared with the control group (Fig. 3A).
However, exposure of 3T3-L1 cells to PTX (10 μM) significantly in-
creased glucose consumption (101.6 ± 16.8 μmol/106 cells) as com-
pared with caffeine (49.7 ± 10.5 μmol/106 cells), but not with control
group (74.8 ± 10.7 μmol/106 cells). To further evaluate if the in-
creased glucose consumption was associated with increased glycolytic
activity, we quantified pyruvate (Fig. 3B) and glutamine (Fig. 3C)
consumption, as well as lactate (Fig. 3D), alanine (Fig. 3E), and acetate
(Fig. 3F) production. Cells exposed to PTX 10 μM presented a sig-
nificantly higher pyruvate and glutamine consumption
(12.1 ± 3.0 μmol/106 cells and 28.1 ± 4.4 μmol/106 cells, respec-
tively) when compared to caffeine 10 μM (4.7 ± 1.0 μmol/106 cells
and 13.7 ± 2.8 μmol/106 cells, respectively), although no differences
where observed when compared with the control group (7 ± 1 μmol/
106 cells and 20 ± 3 μmol/106 cells respectively). Moreover, PTX
Fig. 2. – Evaluation of the metabolic activity as determined by MTT assay (A)
and quantification of the released lactate dehydrogenase (LDH) (B) by 3T3-L1
cells after 24 h treatment with 8-(3-phenylpropyl)-1,3,7-triethylxanthine (PTX)
or caffeine (0.1, 1, 10 and 100 μM). Results are expressed as fold variation to
control and mean ± SEM (n=5 for each condition). Significantly different
results (p < .05) are indicated as: a) relative to control; h) relative to caffeine
100 μM.
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(10 μM) also increased lactate and alanine production
(38.5 ± 5.9 μmol/106 cells and 41 ± 0.6 μmol/106 cells, respec-
tively), as compared with caffeine (22 ± 5 μmol/106 cells and
2.0 ± 0.4 μmol/106 cells, respectively), but not when compared with
the control group (29.9 ± 2.9 μmol/106 cells and 3.2 ± 0.4 μmol/106
cells respectively). Our results also demonstrated an significant increase
in acetate production and export from 3T3-L1 cells exposed to PTX 0.1
or 10 μM (2.4 ± 0.3 μmol/106 cells and 2.7 ± 0.3 μmol/106 cells,
respectively) relatively to those exposed to the same concentrations of
caffeine (1.3 ± 0.3 μmol/106 cells and 1.6 ± 0.4 μmol/106 cells, re-
spectively), although no differences where observed when compared
with the control group (2.0 ± 0.3 μmol/106 cells).
3.3. PTX decreases protein oxidation in 3T3-L1 cells as compared with
caffeine
Protein carbonyl groups represent an irreversible form of protein
damage induced by oxidative stress. 3T3-L1 cells exposed to caffeine 1
and 10 μM for 24 h demonstrated a significantly higher protein car-
bonyl content (2.7 ± 0.4-fold and 2.2 ± 0.4-fold variation to control,
respectively) relative to the control group (Fig. 4A). Contrastingly, PTX
did not alter protein carbonyl content when compared to the control
group. However, there was a significant decrease in protein carbonyl
content of 3T3-L1 cells exposed to 1 μM (0.41 ± 0.06-fold variation to
control) or 10 μM (0.49 ± 0.08-fold variation to control) of PTX re-
lative to those exposed to the same concentrations of caffeine. Con-
cerning protein nitration (Fig. 4B) and lipid peroxidation (Fig. 4C),
exposure to caffeine or PTX did not alter both parameters.
Fig. 3. – Consumption of glucose (A), pyruvate (B), and glutamine (C), and production of lactate (D), alanine (E), and acetate (F) in 3T3-L1 cells after 24 h treatment
with 8-(3-phenylpropyl)-1,3,7-triethylxanthine (PTX) or caffeine (0.1, 1 and 10 μM). Results are expressed as μmol/106 cells and mean ± SEM (n=6 for each
condition). Significantly different results (p < .05) are indicated as: b) relative caffeine 0.1 μM caffeine; f) relative to caffeine 10 μM.
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4. Discussion
Caffeine is one of the most well-characterized substances world-
wide. Its consumption is generally considered safe, although toxic ef-
fects to humans were reported when plasma concentrations reached
200 μM (Fredholm 1985), while at 1mM range it is considered fatal
(Anderson et al. 1999). In fact, caffeine is described to induce cellular
death by apoptosis. Several mechanisms are proposed, such as apop-
tosis via caspase-dependent apoptosis (Kuwayama 2012), cell cycle
modulation via p53 and caspases pathway (Bode and Dong 2007; He
et al. 2003), or stimulation of autophagy via PI3K/Akt/mTOR pathway
(Saiki et al. 2011).
The concentrations selected to be tested in this study were based on
the predicted plasma concentrations achieved by regular consumption
of caffeine. Caffeine content in coffee depends on the variety of beans
(Coffea arabica or Coffea robusta), production, and preparation. In
general, a regular cup of coffee contains 95–330mg of caffeine
(200mL), instant coffee 30–70mg of caffeine (200mL), while expresso
presents high caffeine content, with 50–150mg of caffeine (30mL)
(Gonzalez de Mejia and Ramirez-Mares 2014). Caffeine is readily ab-
sorbed by the human body, with a bioavailability near to 100%,
reaching a plasma peak within 15–45min when administered by oral
route (Sepkowitz 2013). Moreover, an oral intake of 100mg of pure
caffeine lead to plasma concentrations between 9 and 12 μM
(Teekachunhatean et al. 2013). Since PTX demonstrated higher ade-
nosine A1 receptor affinity than caffeine, two lower concentrations of
0.1 and 1 μM and a higher concentration of 100 μM were included. Our
results showed that caffeine 100 μM significantly impaired cellular
metabolic activity and increased LDH release in the extracellular
medium, suggesting 3T3-L1 cytotoxicity. In order to remove the cyto-
toxic variable from the subsequent assays, the higher concentration of
100 μM was removed. Notably, PTX presented no cytotoxicity signs for
any of the concentrations tested. These results suggest that PTX could
be a safer alternative to caffeine, which is a promising feature for
pharmaceutical application.
Caffeine is a known thermogenic and metabolic modulator (Dulloo
2011). It is reported to modulate glucose metabolism and increase en-
ergy expenditure (Lopes-Silva et al. 2015). Simultaneously, caffeine
consumption appears to be inversely related with weight gain (Davoodi
et al. 2014; Icken et al. 2015; Schubert et al. 2014). One possible ex-
planation for these observations could be related to the effects derived
from the adenosine receptors antagonism. It has been reported that
adenosine receptors inhibition induces glycolysis, increasing glucose
uptake and lactate production (Duarte et al. 2016; Gao et al. 1997).
Simultaneously, the antagonism of adenosine A1 receptors lead to li-
polysis (Szkudelski et al. 2009). Since PTX has higher affinity for A1
receptors (Ki of 0.164 μM (Van der Walt and Terre'Blanche 2015), while
caffeine Ki is about 40–50 μM (Magkos and Kavouras 2005)), we hy-
pothesized that it could have stronger metabolic effects than caffeine. In
fact, when compared with caffeine, PTX 10 μM significantly increased
glucose, pyruvate, and glutamine consumption, and lactate and alanine
production. Acetate production was significantly increased even at the
lowest dose (0.1 μM). Our results suggest that PTX stimulates the gly-
colytic pathway with a higher efficiency and at considerably lower
concentrations than caffeine.
Increased metabolic activity, however, can lead to increased oxi-
dative stress levels (Dias et al. 2017). This type of damage plays an
important role in pathophysiology of several diseases, including obesity
(Marseglia et al. 2014). Caffeine is usually reported as an antioxidant
and associated with reduced oxidative stress biomarkers (Grucka-
Mamczar et al. 2009; Monteiro et al. 2018). Additionally, it has been
described as a protective agent against cellular damage (Ofluoglu et al.
2009) and as an efficient radical scavenger in vitro (Shi and Daly 1999).
Caffeine protective effect against oxidative stress was previously asso-
ciated with adenosine receptors antagonism that regulates free radicals
formation (Gołembiowska and Dziubina 2012). However, some studies
reported that caffeine could not protect cells against oxidative stress
(Baeza et al. 2014; Inkielewicz-Stepniak and Czarnowski 2010) or may
even act as prooxidant (Azam et al. 2003; Gulcin 2008). In our study,
we observed that caffeine (1 and 10 μM) significantly increased protein
carbonyl content, a common biomarker for protein oxidation. These
results suggest that caffeine, at these conditions, acts as a prooxidant
and exacerbates the protein damage caused by oxidative stress. In fact,
caffeine was previously reported to induce a prooxidant environment in
Sertoli cells at the same concentration range (Dias et al. 2015). Another
study in U937 cells reported that a concentration of 50 μM of caffeine
Fig. 4. – Effects of 24 h treatment with 8-(3-phenylpropyl)-1,3,7-triethyl-
xanthine (PTX) or caffeine (0.1, 1 and 10 μM) in carbonyl groups formation (A),
tyrosine residues nitration (B) and lipid peroxidation (C) in 3T3-L1 cells. Results
are expressed as fold variation to control and mean ± SEM (n=6 for each
condition). Significantly different results (p < .05) are indicated as: a) relative
to control; d) relative to caffeine 1 μM; f) relative to caffeine 10 μM.
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also significantly increased reactive oxygen species (ROS) production
(Liu and Chang 2010). Moreover, caffeine is reported to increase in-
tracellular ROS levels in osteoblasts, causing apoptosis (Lu et al. 2008).
Thus, caffeine effects may depend on the association between cell type
and concentration, although the mechanisms behind antioxidant/
prooxidant activity are yet to be full elucidated. On the other hand, PTX
did not alter protein oxidation as compared with the control group and
decreased protein oxidation as compared with caffeine, which points
out that this new compound does not comprise prooxidant effects.
Additionally, PTX or caffeine did not increase lipid peroxidation or the
nitration of tyrosine residues in proteins, two other common bio-
markers for oxidative stress. These results additionally support the
observation that PTX effectively enhances cellular metabolic activity
without inducing oxidative stress.
In summary, our results highlight that PTX at the studied conditions
does not induce cytotoxicity even at similar concentrations of caffeine
which are toxic. Moreover, PTX is a greater modulator of cellular me-
tabolic activity than caffeine, while reducing protein oxidation and
protecting cells against oxidative stress-induced damage. These results
illustrate that PTX is a synthetic substitute for caffeine with higher
metabolic modulating potential and an excellent candidate for novel
drug design.
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